7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,295.26

-257.09

-0.33%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

XETRA - Delayed Quote EUR

Fresenius Medical Care AG (FME.DE)

40.40 -1.07 (-2.58%)

At close: October 30 at 5:35:27 PM GMT+1

Loading Chart for FME.DE

Chart Range Bar

Interval:

In partnership with ChartIQ

Fresenius Medical Care (XTRA:FME) Faces EU Setback After TAVNEOS Revocation Recommendation

Fresenius Medical Care (XTRA:FME) Faces EU Setback After TAVNEOS Revocation Recommendation

Fresenius Medical Care dips after US proposes lower dialysis reimbursement rate

Fresenius Medical Care dips after US proposes lower dialysis reimbursement rate

Assessing Fresenius Medical Care (XTRA:FME) Valuation After Recent Share Price Weakness

Assessing Fresenius Medical Care (XTRA:FME) Valuation After Recent Share Price Weakness

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months

Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months

Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care

Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care

Fresenius Medical Care's (ETR:FME) Solid Earnings Have Been Accounted For Conservatively

Fresenius Medical Care's (ETR:FME) Solid Earnings Have Been Accounted For Conservatively

Fresenius Medical Care AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Fresenius Medical Care AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Fresenius Medical Care AG & Co. KGaA Q1 Earnings Call Highlights

Fresenius Medical Care AG & Co. KGaA Q1 Earnings Call Highlights

Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed

Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed

CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union

CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union

Mobilize your Website

View Site in Mobile | Classic

Share by: